Clinical Research Directory
Browse clinical research sites, groups, and studies.
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Sponsor: Assiut University
Summary
1. Assesement of response to Thrombopoietin receptor agonists (TPO-RAs) as treatment in Idiopathic thrombocytopenia purpura patients in Assiut University hospital. 2. Explore side effects of Thrombopoietin receptor agonists in Idiopathic thrombocytopenia purpura . 3. To study effect of thrombopoietin receptor agonists and Quality life in Idiopathic thrombocytopenia purpura patients.
Official title: A Study of Treatment With Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-12-01
Completion Date
2026-12
Last Updated
2023-11-18
Healthy Volunteers
Not specified
Conditions
Interventions
eltrombopag and romiplastim
Group I: eltrombopag and romiplastim Group II : recived corticosteroid.